StockVS

U.S. Physical Therapy, Inc. (USPH) Stock Analysis

Healthcare

U.S. Physical Therapy, Inc.

$62.11

+$0.15 (+0.24%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

U.S. Physical Therapy, Inc. operates and manages outpatient physical therapy clinics through two distinct segments: Physical Therapy Operations and Industrial Injury Prevention Services. The organization provides comprehensive pre- and post-operative care and treatment specifically for orthopedic conditions. This entity functions within the Healthcare sector, classified under the Medical Care Facilities industry, a classification that defines its role in delivering essential patient rehabilitation and clinical support services. The company demonstrates significant scale with a market capitalization of $1.14B, generating annual revenue of $773.34M and employing 4,653 individuals. These valuation and revenue figures indicate that the company holds a substantial position within the medical care facilities landscape, reflecting a large operational footprint and a solidified presence in the outpatient therapy market.

Financial Health

The company reported a revenue of $773.34M and an EBITDA of $103.09M, while net income for the trailing twelve months was $21.57M. The substantial gap between the EBITDA figure and the net income reveals a significant cost structure consisting of interest expenses, taxes, and depreciation that materially impact the bottom line. Despite the high operational earnings, the profit margin stands at 5.1%, indicating that non-operating costs and interest obligations consume a large portion of the generated earnings. The firm generated $73.92M in free cash flow, which provides a critical buffer for financial flexibility to fund operations, manage capital expenditures, or address unexpected liabilities. Regarding liquidity, the company holds $36.31M in cash against $315.16M in total debt, resulting in a debt-to-equity ratio of 40.92. This specific leverage profile suggests the balance sheet is highly leveraged relative to its equity base, which is a notable characteristic for a firm in the healthcare services sector. The current ratio is 1.01, which indicates that the company's short-term assets barely exceed its short-term liabilities, signaling a tight liquidity position with limited cushion against immediate obligations. Furthermore, the return on equity is 7.6% and the return on assets is 4.3%, metrics that reveal how effectively management utilizes shareholder capital and total assets to generate profit, though these returns are modest relative to the company's high valuation multiples.

Valuation Assessment

The stock trades with a P/E ratio of 52.64 on a trailing twelve-month basis, while the forward P/E is significantly lower at 22.57. This sharp difference between the trailing and forward multiples implies that the market expects a substantial increase in earnings in the future to justify the current high price-to-earnings multiple. The price-to-book ratio is 2.37, which indicates that the market is pricing the company at a significant premium over its net asset book value. Additionally, the price-to-sales ratio is 1.47 and the EV/EBITDA stands at 16.52, suggesting that valuation is being driven by revenue multiples and enterprise value metrics that may reflect growth expectations or high cost of capital. Regarding price volatility, the stock has a beta of 1.34, meaning it is more volatile than the broader market and tends to amplify market movements. The 52-week high is $93.50 and the 52-week low is $62.77; without the current specific price point provided in the facts, the analysis focuses on the range itself which defines the trading band for the security.

Growth & Income

The revenue growth rate year-over-year is 12.5%, whereas the earnings growth rate is listed as N/A in the available data. The absence of a reported earnings growth figure suggests that the company may not be consistently reporting comparable year-over-year earnings growth or that the metric is not currently tracked in the standard format used for this analysis. The company pays a dividend with a yield of 2.4%, but the payout ratio is 126.8%. This payout ratio exceeds 100%, indicating that the dividend is not covered by current earnings and is being funded by cash reserves or other sources, which raises questions regarding the sustainability of the dividend relative to reported profitability. Given the high payout ratio and the lack of reported earnings growth, the company appears to rely heavily on cash flow and existing reserves to maintain its dividend rather than reinvesting earnings for expansion. The overall growth and income profile presents a mixed picture where revenue is expanding rapidly, yet profitability metrics and dividend coverage suggest underlying financial constraints that investors must weigh against the dividend yield.

Peer Comparison

U.S. Physical Therapy, Inc. (USPH) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
U.S. Physical Therapy, Inc. USPH $945.24M 124.2
HCA Healthcare, Inc. HCA $87.05B 13.5
Tenet Healthcare Corporation THC $15.19B 9.2
DaVita Inc. DVA $12.55B 18.8

The Medical Care Facilities industry average P/E ratio is 28.6x. U.S. Physical Therapy, Inc. trades at a P/E of 124.2.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

Visit website →

Key Statistics

Market Cap
$945.24M
P/E Ratio
124.22
52-Week High
$93.50
52-Week Low
$58.19
Avg Volume
195.94K
Beta
1.20
Dividend Yield
2.93%

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States
Employees
4,653